English 中文版
Clinical Center
Medical Oncology
Surgery
Gynecologic Oncology
Traditional Chinese Medicine/Integrative Oncology
Radiation Oncology
Anesthesiology
Medical Laboratory

Contact Us

Tel: +86-731-88651900

Fax: +86-731-88651999

Mail: hnszlyy_network@163.com

Add: 283 Tongzipo Road, Yuelu District, Changsha, 410013, Hunan, P.R. China

Doctor Profile Home > Departments > SURGERY > Thoracic Surgery Department 2

Dr. WANG Wenxiang
Thoracic Surgery Department II, Professor&Director
  • Education & Professional Experiences:

    7/1991 M.D., Xiangya School of Medicine, Central South University.

    11/2003 Master Degree, Xiangya School of Medicine, Central South University.

    7/2007 Ph.D., Xiangya School of Medicine, Central South University.

    1/2014 Visitor, Diagnosis and Treatment Center, Department of Thoracic Surgery, Sedars-sinai Hospital. USA.


  • Specialty:

    Minimally invasive and intractable thoracic surgeries.

  • Research:

    Basic and clinical research on lung cancer, development and research on new minimally invasive technology for esophageal cancer.

  • Publications:

    Wang WX, et al. Relationship of CD44, MMPs and its suppressor between infiltration and diversion of tumour. China Journal of Modern Medicine. 2015; 15 (5): 712-715.

    Wang WX, et al. Study on the effects of heat shock protein 70 antisense oligonucleotide on cell growth of Eca-109. Chinese Journal of General Surgery. 2007; 16 (4): 346-349.

    Wang WX, et al. Effect of Shenmai Zhusheye on perioperative cytokines in patients with lung cancer after radical resection. Central South Pharmacy. 2011; 9 (8): 571-573.

    Wang WX, et al. The Influence of Cell Immune Functions in the Elderly Esophageal Cancer Patients Underwent Thoracoscopic and Laparoscopic Surgery. Chinese Journal of Modern Operative Surgery. 2012; 16 (3): 195-197.

    Wang WX, et al. Prognostic Factors of Lung Cancer patients after Surgery: multifactorial analysis of 226 cases. Journal of Clinical Research. 2009; 26 (3).

    Wang WX, et al. Preparation of mB7-1-GPI anchored Lewis tumor cell vaccine and its anti-tumor effect. Journal of Chinese Physician. 2010, 12 (6): 728-731.

    Wang WX, et al. Clinicopathological Significance of MMP2, MMP9, TIMP1 and TIMP2 Expressions in Human Non-small Cell Lung Cancer. Practical Preventive Medicine. 2006; 13 (1): 23-26.

    Wang WX, et al. Study on Positive Expression of Heat Shock Protein 70 and Its Correlation with Prognosis of Esophageal Squamous Cell Carcinoma. 2008; 25 (9): 1571-1574.

    Wang WX, et al. Effect of Blocking STAT3 Signaling Pathway on Invasiveness of Human Non-small Lung Cancer Cells. Journal of Clinical Research. 2009; 26 (5).

    Wang WX, et al. Clinical Analysis of Pulmonary Sclerosing Hemangioma in 24 Cases. Journal of Clinical Research. 2006; 23 (11): 1749-1750.

    Wang WX, et al. Exploration of Immediate Breast Reconstruction After Modified Radical Mastectomy for Breast Cancer Patients. 2005; 22 (5): 631-633.

    Wang WX, et al. Clinical Analysis of Pulmonary Carcinosarcoma in 13 Cases. Journal of Clinical Research. 2007; 24 (4): 592-593.

    Wang WX, et al. Expression and metastasis prognosis of CD44V6 MMP2, MMP9, TIMP1 and TIMP2 in non-small cell lung cancer. China Medical Engineering. 2007; 15 (2): 122-130.

    Wang WX, et al. A Clinical Analysis about Pulmonary Cancer Treated with Total Pneumonectomy. China Journal of Cancer Prevention and Treatment. 2002; 9 (2): 170-171.

    Wang WX, et al. Clinical Exploration for Pleural Normal Saline Cytology during Lung Cancer Surgery. Journal of Clinical Research. 2003; 20 (4): 292-293.

    Wang WX, et al. Influence of Octreotide on Postoperative Flows Volume of the Lung Cancer Patients Receiving Neoadjuvant Chemotherapy before Radical Resection of Pulmonary Arcinoma. 2011; 7 (12): 2877-2878.

    Wang WX, et al. Diagnosis and Treatment of Middle Lobe Lung Cancer. International Medicine and Health Guidance News. 2001 (1).


  • Awards:

    One of first-batch health backbone trained talents of Health and Family Planning Commission of Hunan Province (Project 225)

    Vice chairman of Esophageal Cancer Committee, Hunan Anti-cancer Association 

    Vice chairman of the first digestive tract tumor group, Tumor Committee, Hunan Medical Association

    Member of Cardiothoracic Surgery Committee, Hunan Medical Association

    Member of Hunan Tumor Committee 

    Standing member of Perioperative Medical Management Committee, Hunan Health Management Association

    Member of Hunan Society of Integrated Chinese and Western Medicine

    Member of Hunan Tumor Rehabilitation Committee.

  • Out-patient Schedule:

    Monday Friday morning

  • E-mail:

    Wangwenxiang@hnszlyy.com

Related
News
Newsroom
Notice
Videos
International
Clinical Service
Departments
Find a Doctor
Experts
Request an Appointment
Research & Education
Cancer Research
Clinical Trials
Selected Publications
Graduate Education
Resident Training
Download Center
Nursing
Nursing
About us
Introduction
Leadership
Contact
Q&A